{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:15:22Z","timestamp":1788225322550,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","jprasopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JPRAS Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpra.2026.07.031","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:50:43Z","timestamp":1785253843000},"page":"568-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond the needle: psychosocial and quality-of-life outcomes following facial aesthetic injectable treatments"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2907-4746","authenticated-orcid":false,"given":"Alain","family":"Michon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jpra.2026.07.031_bib0001","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/asj\/sjaa339","article-title":"The facial aging process from the \"Inside Out\"","volume":"41","author":"Swift","year":"2021","journal-title":"Aesthet Surg J"},{"issue":"10","key":"10.1016\/j.jpra.2026.07.031_bib0002","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamadermatol.2018.2357","article-title":"Self-reported patient motivations for seeking cosmetic procedures","volume":"154","author":"Maisel","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.jpra.2026.07.031_bib0003","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/asj\/sjad374","article-title":"I want it to look natural\": development and validation of the FACE-Q aesthetics natural module","volume":"44","author":"Klassen","year":"2024","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.jpra.2026.07.031_bib0004","doi-asserted-by":"crossref","DOI":"10.1093\/asjof\/ojac086","article-title":"Is more better? Benefits of hyaluronic acid soft tissue filler on the psychological- and social-related quality of life dimensions","volume":"4","author":"Michon","year":"2022","journal-title":"Aesthet Surg J Open Forum"},{"issue":"1","key":"10.1016\/j.jpra.2026.07.031_bib0005","first-page":"62","article-title":"Assessing improvement of facial appearance and quality of life after minimally-invasive cosmetic dermatology procedures using the FACE-Q scales","volume":"15","author":"Hibler","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jpra.2026.07.031_bib0006","doi-asserted-by":"crossref","first-page":"NP115","DOI":"10.1093\/asj\/sjab114","article-title":"Multimodal facial aesthetic treatment on the appearance of aging, social confidence, and psychological well-being: HARMONY study","volume":"42","author":"Cohen","year":"2022","journal-title":"Aesthet Surg J"},{"issue":"8","key":"10.1016\/j.jpra.2026.07.031_bib0008","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijsu.2011.08.001","article-title":"Towards evidence-based medicine in surgical practice: best BETs","volume":"9","author":"Khan","year":"2011","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.jpra.2026.07.031_bib0009","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ebm.6.3.70","article-title":"Best BETs","volume":"6","author":"Quin","year":"2001","journal-title":"Evid Based Med"},{"key":"10.1016\/j.jpra.2026.07.031_bib0010","author":"Phillips"},{"issue":"5","key":"10.1016\/j.jpra.2026.07.031_bib0011","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/asj\/sjaf204","article-title":"OnabotulinumtoxinA treatment for masseter muscle prominence: 6-month safety and efficacy results, including patient-reported outcomes, from a phase 3, randomized, placebo-controlled, multiregional trial","volume":"46","author":"Sun","year":"2026","journal-title":"Aesthet Surg J"},{"issue":"2","key":"10.1016\/j.jpra.2026.07.031_bib0012","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/PRS.0000000000012345","article-title":"Improvement of lower facial shape after treatment with OnabotulinumtoxinA: secondary results from a phase 2 dose escalation study","volume":"157","author":"Liew","year":"2026","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.jpra.2026.07.031_bib0013","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.70821","article-title":"Patient-reported outcomes after treatment with OnabotulinumtoxinA for platysma prominence: results from a phase 2 dose-ranging study","volume":"25","author":"Humphrey","year":"2026","journal-title":"J Cosmet Dermatol"},{"issue":"8","key":"10.1016\/j.jpra.2026.07.031_bib0014","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/asj\/sjaf063","article-title":"Patient-reported outcomes for glabellar line improvement and satisfaction with the RelabotulinumtoxinA ready-to-use liquid formulation: data from the phase 3 READY-1 trial","volume":"45","author":"Gold","year":"2025","journal-title":"Aesthet Surg J"},{"issue":"2","key":"10.1016\/j.jpra.2026.07.031_bib0015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/asj\/sjae220","article-title":"Improving neck and jawline aesthetics with OnabotulinumtoxinA by minimizing Platysma muscle contraction effects: efficacy and safety results in a phase 3 randomized, placebo-controlled study","volume":"45","author":"Shridharani","year":"2025","journal-title":"Aesthet Surg J"},{"issue":"6","key":"10.1016\/j.jpra.2026.07.031_bib0016","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/DSS.0000000000004152","article-title":"LetibotulinumtoxinA attenuates the psychological burden of glabellar lines and is associated with high subject satisfaction in phase 3 clinical trials","volume":"50","author":"Cox","year":"2024","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.jpra.2026.07.031_bib0017","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/jocd.14906","article-title":"Subject satisfaction and psychological well-being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines","volume":"21","author":"Dayan","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"10.1016\/j.jpra.2026.07.031_bib0018","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/asj\/sjz248","article-title":"Significantly increased patient satisfaction following liquid formulation AbobotulinumtoxinA treatment in glabellar lines: FACE-Q outcomes from a phase 3 clinical trial","volume":"40","author":"Ascher","year":"2020","journal-title":"Aesthet Surg J"},{"issue":"2","key":"10.1016\/j.jpra.2026.07.031_bib0019","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/DSS.0000000000001940","article-title":"Assessment of psychological well-being after AbobotulinumtoxinA treatment: a comparison of 2 reconstitution volumes","volume":"46","author":"Cohen","year":"2020","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.jpra.2026.07.031_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/DSS.0000000000002047","article-title":"Efficacy, patient-reported outcomes, and safety in male subjects treated with OnabotulinumtoxinA for improvement of moderate to severe horizontal forehead lines","volume":"46","author":"Keaney","year":"2020","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.jpra.2026.07.031_bib0021","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/DSS.0000000000002216","article-title":"Efficacy, patient-reported outcomes, and safety for millennial subjects treated with OnabotulinumtoxinA for moderate to severe horizontal forehead lines","volume":"46","author":"Palm","year":"2020","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.jpra.2026.07.031_bib0022","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/DSS.0000000000001779","article-title":"OnabotulinumtoxinA for treatment of forehead and glabellar lines: subject-reported satisfaction and impact from a phase 3 double-blind study","volume":"45","author":"Ogilvie","year":"2019","journal-title":"Dermatol Surg"},{"issue":"Suppl 1","key":"10.1016\/j.jpra.2026.07.031_bib0023","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/DSS.0000000000000146","article-title":"Effects of OnabotulinumtoxinA treatment for crow's feet lines on patient-reported outcomes","volume":"41","author":"Dayan","year":"2015","journal-title":"Dermatol Surg"},{"issue":"1 Spec No","key":"10.1016\/j.jpra.2026.07.031_bib0024","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1524-4725.2006.32325.x","article-title":"Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study","volume":"33","author":"Fagien","year":"2007","journal-title":"Dermatol Surg"},{"issue":"1 Spec No","key":"10.1016\/j.jpra.2026.07.031_bib0025","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1524-4725.2006.32326.x","article-title":"Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes","volume":"33","author":"Carruthers","year":"2007","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jpra.2026.07.031_bib0026","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/DSS.0000000000002795","article-title":"Safe and effective chin augmentation with the hyaluronic acid injectable filler, VYC-20L","volume":"47","author":"Beer","year":"2021","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jpra.2026.07.031_bib0027","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00266-019-01538-8","article-title":"Psychological analysis of non-surgical rhinoplasty","volume":"44","author":"Di Rosa","year":"2020","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.jpra.2026.07.031_bib0028","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/CIA.S233405","article-title":"Subjective evaluation of the results of injectable hyaluronic acid fillers for the face","volume":"15","author":"Matecka","year":"2020","journal-title":"Clin Interv Aging"},{"issue":"9","key":"10.1016\/j.jpra.2026.07.031_bib0029","doi-asserted-by":"crossref","first-page":"NP499","DOI":"10.1093\/asj\/sjaa013","article-title":"VYC-25L hyaluronic acid injectable gel is safe and effective for long-term restoration and creation of volume of the lower face","volume":"40","author":"Ogilvie","year":"2020","journal-title":"Aesthet Surg J"},{"issue":"10","key":"10.1016\/j.jpra.2026.07.031_bib0030","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/DSS.0000000000001960","article-title":"Safe, effective chin and jaw restoration with VYC-25L hyaluronic acid injectable gel","volume":"45","author":"Ogilvie","year":"2019","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jpra.2026.07.031_bib0031","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/DSS.0000000000001613","article-title":"Assessment of the impact of perioral rejuvenation with hyaluronic acid filler on projected first impressions and mood perceptions","volume":"45","author":"Dayan","year":"2019","journal-title":"Dermatologic Surgery"},{"issue":"5","key":"10.1016\/j.jpra.2026.07.031_bib0032","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/asj\/sjv050","article-title":"A multicenter, single-blind randomized, controlled study of a volumizing hyaluronic acid filler for midface volume deficit: patient-reported outcomes at 2 years","volume":"35","author":"Few","year":"2015","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.jpra.2026.07.031_bib0033","doi-asserted-by":"crossref","DOI":"10.1093\/asjof\/ojag061","article-title":"Socially transformative aesthetics: real-world evidence of positive first impressions after pan-facial aesthetic treatments","volume":"8","author":"Dayan","year":"2026","journal-title":"Aesthet Surg J Open Forum"},{"issue":"4","key":"10.1016\/j.jpra.2026.07.031_bib0034","article-title":"Impact of minimally invasive aesthetic procedures on the psychological and social dimensions of health","volume":"9","author":"McKeown","year":"2021","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"Suppl 4","key":"10.1016\/j.jpra.2026.07.031_bib0035","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1524-4725.2010.01705.x","article-title":"Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg\/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation","volume":"36","author":"Carruthers","year":"2010","journal-title":"Dermatol Surg"},{"issue":"suppl 3","key":"10.1016\/j.jpra.2026.07.031_bib0036","doi-asserted-by":"crossref","DOI":"10.1590\/0001-3765202420240402","article-title":"Clinical evaluation of combined autologous platelet-rich plasma and volume-controlled ozone therapy in facial rejuvenation: a randomized controlled pilot study","volume":"96","author":"Camargo","year":"2024","journal-title":"An Acad Bras Cienc"},{"issue":"10","key":"10.1016\/j.jpra.2026.07.031_bib0037","article-title":"Cosmetic injectable treatments improve quality of life in patients with multiple serious medical comorbidities","volume":"15","author":"Rullan","year":"2023","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.jpra.2026.07.031_bib0038","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/asj\/sjx179","article-title":"Impact of comprehensive, minimally invasive, multimodal aesthetic treatment on satisfaction with facial appearance: the HARMONY study","volume":"38","author":"Weinkle","year":"2018","journal-title":"Aesthet Surg J"},{"issue":"1","key":"10.1016\/j.jpra.2026.07.031_bib0039","first-page":"48","article-title":"Randomized study to assess the efficacy of skin rejuvenation therapy in combination with neurotoxin and full facial filler treatments","volume":"17","author":"Dayan","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jpra.2026.07.031_bib0040","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1097\/DSS.0000000000000548","article-title":"Patient satisfaction and efficacy of full-facial rejuvenation using a combination of botulinum toxin type A and hyaluronic acid filler","volume":"41","author":"Molina","year":"2015","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jpra.2026.07.031_bib0041","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00266-012-9992-0","article-title":"Assessment of quality of life in patients who underwent minimally invasive cosmetic procedures","volume":"37","author":"de Aquino","year":"2013","journal-title":"Aesthetic Plast Surg"}],"container-title":["JPRAS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352587826002718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352587826002718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:47:50Z","timestamp":1788223670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352587826002718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["S2352587826002718"],"URL":"https:\/\/doi.org\/10.1016\/j.jpra.2026.07.031","relation":{},"ISSN":["2352-5878"],"issn-type":[{"value":"2352-5878","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the needle: psychosocial and quality-of-life outcomes following facial aesthetic injectable treatments","name":"articletitle","label":"Article Title"},{"value":"JPRAS Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpra.2026.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons.","name":"copyright","label":"Copyright"}]}}